Awareness about the suspension of Johnson & Johnson’s COVID vaccine


April 13, 2021-after receiving a rare report Blood clot Among those receiving Johnson & Johnson’s COVID-19 vaccine, FDA and CDC recommend suspension of use vaccine, Pending further investigation.

Here, what you need to know:

Why is it recommended to suspend?

After reviewing the data, these agencies found six reports, with few people experiencing these reports Blood clot Combines minimal low platelets blood cells And participate in coagulation. Six reports were found out of the 6.8 million doses given. The FDA and CDC began to suspend “out of prudence.”

What else is known?

According to the joint statement of the CDC and FDA, all six cases are between 18-48 years old. Symptoms appear 6-13 days after vaccination.The type of clot is medically called cerebral vein sinus Thrombosis (CVST) with low levels of platelets.Go here to learn more About these types of blood clots.

In these six cases, a woman died. The other is in a critical state.

The CDC and FDA say that the treatment of this clot is different from other clots.Usually, anticoagulants heparin, Used for. But for this kind of blood clot, other treatments may be needed.

Why does it happen?

Robert Gratt said: “We don’t have a definitive answer yet, but it seems to involve the immune response related to Johnson & Johnson vaccine, which adversely affects platelet function, thereby preventing the normal blood clotting process from occurring.”, MD, New York City Emergency doctor at Lenox Mountain Hospital.

He said that this explanation “may ultimately be related to the adenoviral vector [used in the vaccine] itself. “

Why does it seem to have a greater impact on women than men?

Dr. William Schaffner, a professor of preventive medicine and an infectious disease expert at the Vanderbilt University Medical Center in Nashville, said that it is still unclear. “It is true for AstraZeneca. [vaccine] He says. “If this is an immunization-related problem, then women usually have more such problems than men.”

What should people vaccinated by Johnson & Johnson do?

Remember, there are very few reports of blood clots, Schaffner suggests. According to six reports out of 6.8 million doses of vaccine, the probability is about one in a million. He said: “This actually proves the sensitivity of our vaccine safety system.”

The FDA and CDC say that people who are vaccinated should be vigilant. If you receive the Johnson & Johnson vaccine and have a severe headache, stomach acheIf you experience leg pain, shortness of breath or shortness of breath within three weeks after vaccination, please contact your health care provider.

How long will the suspension last?

This is not yet known. The CDC’s Advisory Committee on Immunization Practices (ACIP) will meet on Wednesday to further review these cases and “evaluate their potential significance.” The FDA is also reviewing the data further.

WebMD Health News


CDC: “Joint Statement of CDC and FDA on Johnson & Johnson’s COVID-19 Vaccine.”

Johnson & Johnson: “Johnson & Johnson’s statement on the COVID-19 vaccine.”

William Schaffner, MD, professor of preventive medicine and infectious disease expert at Vanderbilt University Medical Center in Nashville.

Robert Glatter, MD, is an emergency physician at Lenox Hill Hospital in New York.

©2021 WebMD, LLC. all rights reserved.


Source link

Leave a Reply

Your email address will not be published. Required fields are marked *